X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
index medicus (18) 18
female (11) 11
male (9) 9
middle aged (8) 8
adult (7) 7
aged (7) 7
glioblastoma (7) 7
glioblastoma multiforme (7) 7
bevacizumab (6) 6
cell biology (6) 6
clinical neurology (6) 6
glioblastoma - pathology (6) 6
animals (5) 5
article (5) 5
brain neoplasms - drug therapy (5) 5
brain neoplasms - genetics (5) 5
brain neoplasms - metabolism (5) 5
brain neoplasms - pathology (5) 5
cell line, tumor (5) 5
glioma (5) 5
surgery (5) 5
brain neoplasms - diagnostic imaging (4) 4
cancer (4) 4
glioblastoma - diagnostic imaging (4) 4
glioblastoma - drug therapy (4) 4
glioblastoma - genetics (4) 4
nitric oxide (4) 4
patients (4) 4
rats, nude (4) 4
subarachnoid hemorrhage (4) 4
temozolomide (4) 4
tumors (4) 4
aged, 80 and over (3) 3
analysis (3) 3
aneurysm (3) 3
aneurysmal subarachnoid hemorrhage (3) 3
aneurysms (3) 3
apoptosis (3) 3
azo compounds - pharmacology (3) 3
brain neoplasms - mortality (3) 3
care and treatment (3) 3
cell survival - drug effects (3) 3
discharge (3) 3
glioblastoma - metabolism (3) 3
glioblastoma - mortality (3) 3
glioma - metabolism (3) 3
gliomas (3) 3
hemorrhage (3) 3
intracranial aneurysms (3) 3
js-k (3) 3
oncology (3) 3
piperazines - pharmacology (3) 3
prognosis (3) 3
radiotherapy (3) 3
rats (3) 3
research paper (3) 3
retrospective studies (3) 3
risk factors (3) 3
survival (3) 3
survival analysis (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
acid sphingomyelinase (2) 2
activation (2) 2
angiogenesis (2) 2
angiogenesis inhibitors (2) 2
angiography (2) 2
antiangiogenic therapy (2) 2
antineoplastic activity (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis - drug effects (2) 2
blotting, western (2) 2
brain - metabolism (2) 2
brain cancer (2) 2
brain neoplasms - blood supply (2) 2
brain neoplasms - radiotherapy (2) 2
brain research (2) 2
cell proliferation - drug effects (2) 2
cell survival (2) 2
cells in-vitro (2) 2
colleges & universities (2) 2
confidence intervals (2) 2
dacarbazine - analogs & derivatives (2) 2
data processing (2) 2
disease progression (2) 2
disease-free survival (2) 2
dna methylation (2) 2
endothelial growth-factor (2) 2
endovascular procedures (2) 2
gene expression regulation, neoplastic - drug effects (2) 2
gene regulatory networks (2) 2
genes (2) 2
genome-wide expression (2) 2
glioblastoma - radiotherapy (2) 2
glioma - drug therapy (2) 2
growth factors (2) 2
hydrocephalus (2) 2
immunohistochemistry (2) 2
intracranial vasospasm (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1100 - 1108
Journal Article
The Lancet, ISSN 0140-6736, 02/2019, Volume 393, Issue 10172, pp. 678 - 688
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 1/2015, Volume 129, Issue 1, pp. 115 - 131
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 01/2016, Volume 8, Issue 1, pp. 39 - 57
Glioblastoma multiforme (GBM) is treated by surgical resection followed by radiochemotherapy. Bevacizumab is commonly deployed for anti‐angiogenic therapy of... 
macrophage polarization | anti‐angiogenic therapy | glioblastoma | tumor angiogenesis | therapy resistance | Tumor angiogenesis | Anti-angiogenic therapy | Therapy resistance | Macrophage polarization | Glioblastoma | MEDICINE, RESEARCH & EXPERIMENTAL | anti-angiogenic therapy | NEWLY-DIAGNOSED GLIOBLASTOMA | OVARIAN-CANCER | SERUM ANGIOPOIETIN-2 | ANTIANGIOGENIC THERAPY | COLORECTAL-CANCER | TIE2-EXPRESSING MONOCYTES | POTENT ANTITUMOR | TUMOR-ASSOCIATED MACROPHAGES | DISEASE PROGRESSION | Mannose-Binding Lectins - metabolism | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - pharmacology | Humans | Receptors, Vascular Endothelial Growth Factor - pharmacology | Recombinant Fusion Proteins - therapeutic use | Brain Neoplasms - pathology | Drug Resistance, Neoplasm | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Angiopoietin-2 - metabolism | Brain - metabolism | Lectins, C-Type - metabolism | Neoplasm Grading | Female | Brain Neoplasms - mortality | Macrophages - immunology | Angiopoietin-2 - blood | Disease Models, Animal | Endothelial Cells - metabolism | Mice, Inbred C57BL | Receptors, Cell Surface - metabolism | Mice, Transgenic | Macrophages - cytology | Brain Neoplasms - drug therapy | Up-Regulation - drug effects | Macrophages - metabolism | Animals | Signal Transduction - drug effects | Endothelial Cells - cytology | Glioblastoma - pathology | Brain - pathology | Mice | Angiopoietin-2 - antagonists & inhibitors | Glioblastoma - drug therapy | Glioblastoma - mortality | Analysis | Permeability | Angiogenesis inhibitors | T cells | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Endothelium | Cell survival | Angiopoietin | Therapeutic applications | Brain cancer | Lymphocytes T | Macrophages | Cancer therapies | Investigations | Endothelial cells | Bevacizumab | Angiogenesis | Genotype & phenotype | Brain research | Rodents | Growth factors | Tumors | Neuroscience | Pharmacology & Drug Discovery | Cancer
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article